Skip to main content

What the FDA labels say about taking them together

Acellular tissue engineered vessel and aspirin

Acellular tissue engineered vessel's FDA label of December 9, 2025 names aspirin in its contraindications section; the aspirin label PlainMeds reads does not name acellular tissue engineered vessel. The acellular tissue engineered vessel label: “CONTRAINDICATIONS DO NOT use SYMVESS in patients who have a medical condition that would preclude long-term antiplatelet therapy after resolution of acute injuries.”

Check it at the source: the acellular tissue engineered vessel FDA label on DailyMed (effective December 9, 2025); the aspirin FDA label on DailyMed (effective September 9, 2025).

What does the acellular tissue engineered vessel label say about aspirin?

Acellular tissue engineered vessel label, contraindications

CONTRAINDICATIONS DO NOT use SYMVESS in patients who have a medical condition that would preclude long-term antiplatelet therapy (such as aspirin or clopidogrel) after resolution of acute injuries.

Source: FDA drug label (Symvess), Humacyte Global, Inc., effective December 9, 2025 (SPL set 15e9e29f-5aa6-4fc6-b0fe-a48cd1473418), via openFDA; the full label on DailyMed

What does the aspirin label say about acellular tissue engineered vessel?

Aspirin's label (effective September 9, 2025) does not name acellular tissue engineered vessel in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Medique Products Aspirin), Unifirst First Aid Corporation, effective September 9, 2025 (SPL set 9b28fed0-a993-ca72-e053-2995a90ac7fd), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Acellular tissue engineered vessel generic labelers
0Aspirin generic labelers
Acellular tissue engineered vesselAspirin
Labeled forn/aPain, Cough and cold, Fever
Boxed warningYesNo
Pharmacy cost (NADAC)n/a$0.0142 per tablet 81 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?